PATIENTS AS A DIRECT SOURCE OF INFORMATION ON ADVERSE DRUG-REACTIONS

被引:52
作者
MITCHELL, AS [1 ]
HENRY, DA [1 ]
SANSONFISHER, R [1 ]
OCONNELL, DL [1 ]
机构
[1] ROYAL NEWCASTLE HOSP,CTR CLIN EPIDEMIOL & BIOSTAT,NEWCASTLE,NSW 2300,AUSTRALIA
关键词
D O I
10.1136/bmj.297.6653.891
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:891 / 893
页数:3
相关论文
共 11 条
[1]   A METHODOLOGIC STUDY OF POST-MARKETING DRUG-EVALUATION USING A PHARMACY-BASED APPROACH [J].
BORDEN, EK ;
LEE, JG .
JOURNAL OF CHRONIC DISEASES, 1982, 35 (10) :803-816
[2]   POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - MORTALITY DURING 2ND, 3RD, AND 4TH YEARS OF FOLLOW UP [J].
COLINJONES, DG ;
LANGMAN, MJS ;
LAWSON, DH ;
VESSEY, MP .
BMJ-BRITISH MEDICAL JOURNAL, 1985, 291 (6502) :1084-1088
[3]   POSTMARKETING DRUG SURVEILLANCE BY RECORD LINKAGE IN TAYSIDE [J].
CROMBIE, IK ;
BROWN, SV ;
HAMLEY, JG .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1984, 38 (03) :226-231
[4]  
FEINSTEIN AR, 1975, CLIN PHARMACOL THER, V17, P104
[5]   PATIENT-INITIATED POSTMARKETING SURVEILLANCE - A VALIDATION-STUDY [J].
FISHER, S ;
BRYANT, SG ;
SOLOVITZ, BL ;
KLUGE, RM .
JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (11) :843-854
[6]  
Fisher S, 1987, DRUG INF J, V21, P173
[7]  
Fleiss JL, 1981, STATISTICAL METHODS, P217
[9]  
JICK H, 1984, PHARMACOTHERAPY, V4, P99
[10]  
Luscombe FA, 1985, DRUG INF J, V19, P269